DJIA 17,113.54 61.81 0.36%
NASDAQ 4,456.02 31.31 0.71%
S&P 500 1,983.53 9.90 0.50%
market minute promo

Pain Therapeutics, Inc. (NASDAQ: PTIE)

4.80 0.01 (0.21%)

REAL-TIME: Last trade at

Extended Hours: $4.80 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PTIE $4.80 0.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.80
Previous Close $4.79
Daily Range $4.76 - $4.91
52-Week Range $2.16 - $6.22
Market Cap $218.9M
P/E Ratio 7.60
Dividend (Yield) $0.00 (0.0%)
Volume 107,690
Average Daily Volume 423,430
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drugs

Pain Therapeutics, Inc. (PTIE) Description

A biopharmaceutical company that develops novel drugs for pain management and oncology. Website: http://www.paintrials.com/

News & Commentary

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month

Oversold Conditions For Pain Therapeutics (PTIE)

Morning Coffee: Real-Time Picks

Pain Therapeutics (PTIE) Enters Overbought Territory - Tale of the Tape

SA PRO: Top Long And Short Ideas, Thursday February 27

10 Reasons To Buy Durect Right Now

Strength Seen in Pain Therapeutics Inc. (PTIE) Stock Surges 24% - Tale of the Tape

Can Nektar Therapeutics Beat Pfizer Inc.?

In addition to Remoxy, Pfizer has an in-house formulation of abuse-resistant oxycodone in late stage trials. Could an all new opioid from Nektar Therapeutics upend both programs?

Recent News At Durect Points To Bright Future

Elite Pharmaceuticals: Swinging For The Fences

See More PTIE News...

PTIE's Top Competitors

PTIE $4.80 (0.21%)
Current stock: PTIE
JNJ $102.47 (1.18%)
Current stock: JNJ
NVS $89.26 (0.76%)
Current stock: NVS
RHHBY $36.83 (0.30%)
Current stock: RHHBY